Photo taken from: Peter Lebowitz/LinkedIn
Oct 21, 2023, 23:53
Peter Lebowitz: Three Phase 3 lung cancer readouts in the Presidential Symposium and 4 late-breaker presentations in genitourinary cancers
Peter Lebowitz, SVP, Global Oncology Therapeutic Area Head at Janssen/Johnson and Johnson, made the following post on LinkedIn:
“Three Phase 3 lung cancer readouts in the Presidential Symposium and 4 late-breaker presentations in genitourinary cancers (bladder cancer and prostate cancer).
It’s great to be on the ground at ESMO – European Society for Medical Oncology in Madrid with our best-in-industry Johnson & Johnson Innovative Medicine Oncology team seeing first-hand the advances in solid tumor science and innovation for patients.”
Source: Peter Lebowitz/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 19:09
Apr 1, 2025, 18:48
Apr 1, 2025, 18:37
Apr 1, 2025, 18:26
Apr 1, 2025, 18:22